Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
5
×
cancer drugs
5
×
life sciences
national blog main
clinical trials
san francisco blog main
ipo
national top stories
san francisco top stories
sanofi
blueprint medicines
eli lilly
europe blog main
fda
investing
non-small cell lung cancer
revolution medicines
roche
san francisco
the column group
third rock ventures
warp drive bio
agios pharmaceuticals
amgen
avapritinib
black diamond therapeutics
bladder cancer
boston
capmatinib
cobimetinib
colorectal cancer
david e. shaw
deals
deciphera pharmaceuticals
drug discovery
enasidenib
endometral cancer
What
medicines
5
×
cancer
ipo
drug
research
proteins
revolution
targets
address
approval
approves
biotech
black
blueprint
cancer’s
carries
certain
clinic
companies
company’s
course
designed
despite
development
diamond
discover
disease
eluded
experimental
family
fda
frontiers
genetic
growing
handiwork
hardest
helped
hit
hopes
hottest
Language
unset
5
×
Current search:
medicines
×
cancer
×
unset
×
" cancer drugs "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic